Ciprofloxacin (Cipro, BAYQ3939)

DRUG3 trials

Sponsors

Bayer

Conditions

BronchiectasisPneumoniaPseudomonas Infection

Phase 1

Cipro Inhaler for Cystic Fibrosis Children Ages 6-12

CompletedNCT00910351

BayerPseudomonas Infection

Start: 2009-07-31End: 2010-10-31Updated: 2013-11-21

Phase 2

Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis

CompletedNCT00930982

BayerBronchiectasis

Start: 2009-06-30End: 2010-09-30Updated: 2014-12-12

Phase 3

A Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics/Pharmacodynamics of BAYQ3939 in Patients With Bacterial Pneumonia

CompletedNCT01561794

Start: 2012-05-31End: 2015-03-31Updated: 2015-04-27

Related Papers

Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study.

2012-09-27143 citations